Etodolac Tablets Suppliers & Bulk Manufacturers
Available Forms: Oral Tablets
Available Strengths: 200 mg, 300 mg, 400 mg, 500 mg
Reference Brands: Lodine(US & EU)
Category:
Analgesic
Etodolac inhibits cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis responsible for pain and inflammation. Benefits include effective relief from arthritis pain, inflammation, and osteoarthritis, with a favorable safety profile. Its once or twice daily dosing offers convenient, targeted treatment for chronic pain conditions.
Etodolac tablets is available in Oral Tablets
and strengths such as 200 mg, 300 mg, 400 mg, 500 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Etodolac tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Etodolac tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Etodolac tablets are approved in the EU and US for managing arthritis and inflammatory pain. In the EU, brands like Lodine are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data, biosimilarity, and pharmacovigilance. Both regions require comprehensive dossiers for initial approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support efficient market access for etodolac tablets, ensuring adherence to European and American standards for safe, effective anti-inflammatory therapy, helping you navigate complex regulatory pathways seamlessly.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing